BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12592219)

  • 1. The role of tumor suppressor genes in esophageal cancer.
    Raja S; Godfrey TE; Luketich JD
    Minerva Chir; 2002 Dec; 57(6):767-80. PubMed ID: 12592219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cell and molecular biology of esophageal carcinoma.
    Roth JA
    Chest Surg Clin N Am; 1994 May; 4(2):205-16. PubMed ID: 8049991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The multiple tumor suppressor genes in human esophageal cancer].
    Li HC; Lu SX
    Zhonghua Yi Xue Za Zhi; 1994 Aug; 74(8):489-91, 519. PubMed ID: 7994660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation studies on the alterations of multiple tumor suppressor genes in human esophageal cancer and in human and monkey esophageal epithelial cells treated with N-methyl-N-benzyl nitrosamine].
    Li H; Lu S; Cui X
    Zhonghua Zhong Liu Za Zhi; 1995 Jul; 17(4):249-53. PubMed ID: 7587888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiple tumor suppressor genes in esophageal carcinoma induced in human fetus esophageal epithelium by NMBzA].
    Li H; Lu S; Cui X
    Zhonghua Zhong Liu Za Zhi; 1995 May; 17(3):170-4. PubMed ID: 7656818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular biology of esophageal adenocarcinoma.
    Koppert LB; Wijnhoven BP; van Dekken H; Tilanus HW; Dinjens WN
    J Surg Oncol; 2005 Dec; 92(3):169-90. PubMed ID: 16299787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of NMBzA on the oncogene and multiple tumor suppressor genes in monkey esophageal epithelium].
    Li H; Lu S; Feng L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Feb; 17(1):1-6. PubMed ID: 7781121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenes and oncoproteins as tumor markers.
    Pillai R
    Eur J Surg Oncol; 1992 Oct; 18(5):417-24. PubMed ID: 1426290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel gene, RSRC2, inhibits cell proliferation and affects survival in esophageal cancer patients.
    Kurehara H; Ishiguro H; Kimura M; Mitsui A; Ando T; Sugito N; Mori R; Takashima N; Ogawa R; Fujii Y; Kuwabara Y
    Int J Oncol; 2007 Feb; 30(2):421-8. PubMed ID: 17203224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular control of the cell cycle in cancer: biological and clinical aspects.
    Møller MB
    Dan Med Bull; 2003 May; 50(2):118-38. PubMed ID: 12812137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular prognostic factors in adenocarcinoma of the esophagus and gastroesophageal junction.
    Lagarde SM; ten Kate FJ; Richel DJ; Offerhaus GJ; van Lanschot JJ
    Ann Surg Oncol; 2007 Feb; 14(2):977-91. PubMed ID: 17122988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic pathways in hereditary and sporadic breast cancer.
    Kenemans P; Verstraeten RA; Verheijen RH
    Maturitas; 2004 Sep; 49(1):34-43. PubMed ID: 15351094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.
    Casson AG; Evans SC; Gillis A; Porter GA; Veugelers P; Darnton SJ; Guernsey DL; Hainaut P
    J Thorac Cardiovasc Surg; 2003 May; 125(5):1121-31. PubMed ID: 12771886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathology of pancreatic cancer.
    Hruban RH; Iacobuzio-Donahue C; Wilentz RE; Goggins M; Kern SE
    Cancer J; 2001; 7(4):251-8. PubMed ID: 11561601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular basis for cellular transformation: implications for esophageal carcinogenesis.
    Rosen N
    Semin Oncol; 1994 Aug; 21(4):416-24. PubMed ID: 8042039
    [No Abstract]   [Full Text] [Related]  

  • 18. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
    Tzai TS; Tsai YS; Chow NH
    Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular markers and genetics in cancer development.
    Hormi-Carver K; Souza RF
    Surg Oncol Clin N Am; 2009 Jul; 18(3):453-67. PubMed ID: 19500736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease mechanism and biomarkers of oral squamous cell carcinoma.
    Brinkman BM; Wong DT
    Curr Opin Oncol; 2006 May; 18(3):228-33. PubMed ID: 16552233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.